Product Name :
CARGo – Anti – HLA-G CAR-T Cell Therapy(MD Anderson Cancer Center)
Search keywords :
MHC Class I
drugId :
null
Target Vo:
HLA class I histocompatibility antigen, alpha chain G
Target Vo Short Name :
HLA-G
Moa_Name:
HLA class I histocompatibility antigen, alpha chain G inhibitors
First Approval Country :
First Approval Date Filter:
null
Origin Company_Name :
The University Of Texas MD Anderson Cancer Center
Active Company_Name :
The University Of Texas MD Anderson Cancer Center
Active Indication_Name:
Solid tumours
In Active Indication_Name:
Termination Status :
China Termination Status :
Highest Status:
Phase 2 Clinical
China Highest Status:
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Trastuzumab In Vivo
HMGCS2 Antibody site
SNAI1 Antibody: SNAI1 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-SNAI1 polyclonal antibody. SNAI1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, and predicted: mouse, rat background without labeling.
